Skip to main content
See every side of every news story
Published loading...Updated

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Summary by The Motley Fool
Key Points5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share.This sale represented 10.78% of Andrew Reardon's direct Common Stock holdings, reducing direct ownership to 41,382 shares post-transaction.The transaction involved the immediate exercise and sale of stock options, with no indirect holdings after the event.Reardon retains 39,444 employee stock opti…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Sunday, June 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal